Source:http://linkedlifedata.com/resource/pubmed/id/15553737
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2004-11-19
|
pubmed:abstractText |
We treated a 65-year-old female with gastric cancer who underwent peritoneal dissemination after 6 successive weeks of paclitaxel intraperitoneal therapy (90 mg/body), and obtained a disappearance of ascites and a reduction of the primary carcinoma. Operative findings: U ant, type 5, 26x20 mm, por, T2, n1(+), H0, P0, CY0, M0, stage II, and grade 2. A weekly paclitaxel intraperitoneal therapy could be a useful for both peritoneal dissemination and the primary carcinoma of advanced gastric carcinoma.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0385-0684
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1852-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15553737-Aged,
pubmed-meshheading:15553737-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:15553737-Drug Administration Schedule,
pubmed-meshheading:15553737-Female,
pubmed-meshheading:15553737-Humans,
pubmed-meshheading:15553737-Injections, Intraperitoneal,
pubmed-meshheading:15553737-Neoplasm Seeding,
pubmed-meshheading:15553737-Paclitaxel,
pubmed-meshheading:15553737-Peritoneal Neoplasms,
pubmed-meshheading:15553737-Stomach Neoplasms,
pubmed-meshheading:15553737-Treatment Outcome,
pubmed-meshheading:15553737-Tumor Markers, Biological
|
pubmed:year |
2004
|
pubmed:articleTitle |
[A case of gastric cancer with peritoneal dissemination which shows a remarkable efficacy by a weekly administration of paclitaxel intraperitoneally].
|
pubmed:affiliation |
Dept. of Surgery, Tokyo Metropolitan Health and Medical Treatment Corporation Ohkubo Hospital.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|